Robert W. Baird & Co. Incorporated issued the following announcement on Dec. 8.

Baird, an employee-owned, international financial services firm, announced today that Derrick Li has joined the firm’s Global Investment Banking business as Managing Director on its Global Healthcare Investment Banking team. Li will focus on biopharma, enhancing and expanding the team’s existing areas of expertise. He will be based out of the firm’s New York office.

Li most recently served as Head of Strategy and Investor Relations for Cellular Biomedicine Group, a NASDAQ-listed, biotechnology company that focuses on cell therapies. Prior to Cellular Biomedicine Group, he was a Managing Director in the healthcare investment banking practice at B. Riley FBR. He also spent four years as a Partner at TPP Healthcare, a boutique advisory firm that specializes in cross-border transactions between companies from the U.S. and China. Li began his career as an equity analyst at The Royce Funds. He holds dual bachelor’s degrees in accounting and business administration from Villanova University.

“We are excited that Derrick has decided to continue his career at Baird,” said Rob Andrews, Co-Head of Baird Global Healthcare Investment Banking. “His diverse and complementary set of industry experience and deep healthcare sector knowledge will continue to strengthen our team and overall healthcare offering to our global clients.”

Baird’s Global Healthcare platform has been adding top talent and experiencing strong deal flow momentum in 2020. Derrick is the fourth senior banker to join the firm’s Global Healthcare platform within the past 16 months. Last month, Baird added Adam Huitt in Charlotte to cover pharmaceutical services and Andrew Nicholson in London to lead healthcare coverage in Europe. In July 2019, Baird added Jason Porter in Charlotte to cover physician and alternate site healthcare services.

“Derrick’s addition to the team is another exciting development for Baird and our global Healthcare franchise,” said Bill Suddath, Co-Head of Baird Global Healthcare Investment Banking. “The growth in our team demonstrates our commitment to enhancing our strong sub-sector knowledge and expertise, enabling us to achieve great things for our clients and our business.” 

Li added: “I’m excited to join this highly-regarded team, especially during a time of growth for the Global Healthcare platform. I look forward to utilizing my expertise and delivering the best possible outcomes for our clients.”

Baird’s Global Healthcare platform includes more than 40investment bankers, who have completed 150 healthcare M&A and financing transactions since 2017; 19 Equity Research Analysts covering nearly 150 healthcare stocks; and a dedicated Equity Sales & Trading team that makes a market in approximately 600 healthcare stocks and has traded more than 650 million shares of those stocks in the last twelve months. Baird also recently hosted its annual Healthcare conference. Although it was in a virtual format this year, the conference featured more than 135 presenting companies, 1,700 attendees and 2,300 one-on-one meetings. 

Original source: https://www.rwbaird.com/news/Baird-Investment-Banking-Adds-Derrick-Li-to-Global-Healthcare-Team